Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Intravenous Amantadine Sulphate on Brain Dynamics and Neurobehavioral Status in Patients With Disorders of Consciousness

NCT06443827 is registered in ClinicalTrials.gov with Azienda Sanitaria dell'Alto Adige as lead sponsor.

NCT NCT06443827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06443827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Intravenous Amantadine Sulphate on Brain Dynamics and Neurobehavioral Status in Patients With Disorders of Consciousness
Lead sponsor
Azienda Sanitaria dell'Alto Adige
Phase
Phase 2
Overall status
Unknown status
Start date
September 15, 2018
Completion date
September 30, 2024
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amantadine, consciousness disorders, electroencephalography